Navigation Links
New Data on Vimpat® (lacosamide) C-V to Be Presented at the 65th Annual Meeting of the American Epilepsy Society
Date:11/30/2011

Improved Seizure Severity, Health-Related Quality of Life and Health Status Reported by Patients During Long-Term Treatment with Lacosamide: Analysis of Pooled Open-Label Data
Abstract 2.245; Poster Session 2: Sunday, December 4, 8am – 6pm

4.  Lacosamide Added to Concomitant AEDs Grouped by Mechanism of Action – Impact on Patient-Reported Health-Related Quality of Life in Pooled Phase II/III Trials
Abstract 2.246; Poster Session 2: Sunday, December 4, 8am – 6pm

5.  Lacosamide Has No Effect on The Enzymatic Activity of CYP3A4
Abstract 1.246; Poster Session 1: Saturday, December 3, 11am – 5:30pm

6.  Lacosamide Does Not Alter In Vitro Long-Term Potentiation in Mouse Hippocampal CA1 Area
Abstract 1.266; Poster Session 1: Saturday, December 3, 11am – 5:30pm

About Epilepsy
Epilepsy is a chronic neurological disorder affecting approximately 50 million people worldwide and three million people in the U.S. Anyone can develop epilepsy; it occurs across all ages, races, and genders.  Uncontrolled seizures and medication side effects pose challenges to independent living, learning, and employment, so the goal of epilepsy treatment is seizure freedom with minimal side effects.  In the U.S., more than one million patients continue to have seizures despite initial therapy, and more than 800,000 continue to have seizures despite treatment with two or more therapies.  [1],[2]

About Vimpat®
Vimpat® tablets and injection were launched in the U.S. in May 2009 as an add-on therapy for the treatment of partial-onset seizures in people with epilepsy who are aged 17 years and older.  Vimpat® injection is a short-term replacement when oral administration is not feasible in these patients.  Vimpat® oral soluti
'/>"/>

SOURCE UCB, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New Analysis Shows Potential Cost Savings of Adding Antiepileptic Drug Vimpat® C-V
2. Biodesix Announces New VeriStrat® Data to be Presented at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium
3. XEOMIN® (incobotulinumtoxinA) Data to be Presented at the 72nd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation
4. New Analysis of Data Presented at AHA Regarding Effect of Effient® (Prasugrel) on Cardiovascular Events in STEMI Patients According to Timing of PCI
5. Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
6. Positive Results from Phase 2 Trial of Mesoblasts Adult Stem Cell Therapy Presented at the American Heart Association Annual Meeting
7. Multiple Programs from Merrimack Pharmaceuticals Pipeline to be Presented at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Avanafil Data to be Presented at the Sexual Medicine Society of North America Meeting
9. LX2931 Phase 2 Data to be Presented at the American College of Rheumatology Conference
10. Discovery Labs Releases New AFECTAIR™ Performance Data Presented at the American Association for Respiratory Care Annual Meeting
11. Caliper CEO Kevin Hrusovsky Presented Vision for Revolutionizing Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: Insulin Pump ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong acceptance ...
(Date:1/15/2014)... NEW YORK , Jan. 15, ... new market research report is available ... Global Markets and Technologies for ... on Routes of Administration ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
(Date:4/17/2014)... discovering a new mechanism that allows blood to enter ... Irvine and the Salk Institute have opened the door ... brain damage. , A complex and devastating neurological condition, ... reason for disability in the U.S. The blood-brain barrier ... material into the brain, causing the permanent deficits in ...
(Date:4/17/2014)... April 17, 2014 EcoHealth Alliance, a nonprofit organization ... published a comprehensive review today examining the current state ... The review calls for improved global surveillance strategies to ... recent outbreak of Ebola in West Africa that has ... of Guinea and Liberia. According to the World ...
(Date:4/17/2014)... online has the potential to ward off depression among ... research published online in The Journals of ... . In the article " Internet Use and Depression ... Longitudinal Analysis ," the authors report that Internet use ... percent among their study sample. , Late-life depression ...
(Date:4/17/2014)... and their partners have found that their proprietary microbicide ... of multiple sexually transmitted infections (STIs) in both the ... 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded study ... effective against multiple strains of HIV, and has a ... viruses of at least eight hours prior to exposure. ...
(Date:4/17/2014)... April 17, 2014 Meaningful long-term survival is ... of the abdomen when treated with cytoreductive surgery ... a first-of-its-size analysis by physicians at Wake Forest ... the largest reported, single-center experience with cytoreductive surgery ... M.D., and analysis of 20 years, worth of ...
Breaking Medicine News(10 mins):Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Internet use may cut retirees' depression 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2
... in Sudan Called "Ground-breaking", DUBAI, United Arab ... billion last fall in an 8-week fundraising drive,Dubai ... the recipients of,its Phase One funding. Dubai Cares ... to improving primary education for,children in developing countries., ...
... of Energy,s Brookhaven National Laboratory have shown that increasing ... chemical, can reduce use of cocaine by 75 percent ... this team had similar findings for alcohol intake. Treatments ... receptors -- may prove useful in treating addiction, according ...
... supports hundreds of programs helping millions in the,developing ... WASHINGTON, April 16 The worldwide,pharmaceutical industry today ... biopharmaceutical companies, global,health leaders and policymakers together to ... developing world., Serving as a convening point ...
... The early use of magnetic resonance imaging (MRI) in ... a better adapted surgical approach to the tumour, a ... today (Wednesday April 16). Dr. David Martinez-Cecilia, a ... Rufian-Pea, in the Hospital Universitario Reina Sofia, Cordoba, Spain, ...
... 15 ECO2 Plastics, Inc.,(OTC Bulletin Board: ECOO), ... plastics are recycled, today reported its 2007 year-end,financial ... revenues of,$4.3 million for calendar year 2007 versus ... versus $14.9 million during the prior,year, with net ...
... to clamp the umbilical cord after a baby is born could ... comes with an increased risk of jaundice, according to a new ... seconds after birth is one of three steps in an active ... a new mother is vulnerable to excessive blood loss. Studies show ...
Cached Medicine News:Health News:Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations 2Health News:Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations 3Health News:Dubai Cares Announces 12 Country Plan to Educate and Empower Children in Developing Nations 4Health News:Gene therapy reduces cocaine use in rats 2Health News:Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries 2Health News:Worldwide Pharmaceutical Industry Launches Global Health Progress Initiative to Expand Efforts to Improve Health in Developing Countries 3Health News:MRI before surgery leads to better-adapted treatment for breast cancer 2Health News:ECO2 Plastics, Inc. Reports 2007 Year End Financial Results, Announces FDA Filing and Provides Outlook for 2008 2Health News:ECO2 Plastics, Inc. Reports 2007 Year End Financial Results, Announces FDA Filing and Provides Outlook for 2008 3Health News:Health risks, benefits come with delayed umbilical cord clamping 2
Rigid rake retractor, 3 blunt prongs....
Econo lucae bayonet forceps....
Medpor 2/3 Orbit implants are designed to replace non load bearing bony structures in the orbital area....
... Inferior Orbital Rim implant can provide up ... designed to be trimmed to meet the ... flange allows it to rest on the ... This flange allows easier positioning of the ...
Medicine Products: